[AVDL] YoY Annual Result on 31-Dec-2016 [#FY]

Stock
[AVDL] Avadel Pharmaceuticals plc
Announcement Date
28-Mar-2017
Financial Year
2016
Quarter
31-Dec-2016 [#FY]
Profit Trend
YoY- -201.52%
Quarter Report
AVDL's Result
AVDL's Financial Summary
View:
Show?
Annual Result
31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 CAGR
Revenue 59,215 103,269 172,741 150,246 173,209 14,775 22,443 17.54%
PBT -38,582 -113,197 91,469 -9,718 78,394 -90,331 -54,095 -5.47%
Tax -5,356 -17,893 24,215 31,558 37,735 -1,407 -11,170 -11.52%
NP -33,226 -95,304 67,254 -41,276 40,659 -84,906 -42,925 -4.17%
Tax Rate - - -26.47% - -48.14% - - -
Total Cost 92,441 198,573 105,487 191,522 132,550 99,681 65,368 5.94%
Ratio Analysis
31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 CAGR
NP Margin -56.11 -92.29 38.93 -27.47 23.47 -574.66 -191.26 -18.47%
Per Share
31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 CAGR
EPS -0.89 -2.55 1.66 -1.00 1.00 -2.34 -1.69 -10.13%
EPS Diluted -0.89 -2.55 1.61 -1.00 0.93 -2.34 -1.69 -10.13%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.